PMBCX | VMCCX | PMBCX / VMCCX | |
Total Expense Ratio | 1.75 | 1.95 | 90% |
Annual Report Gross Expense Ratio | 1.75 | 2.04 | 86% |
Fund Existence | 19 years | 16 years | - |
Gain YTD | 7.208 | 4.420 | 163% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 32.9B | 2.75B | 1,197% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 6.69 | 3.75 | 178% |
Returns for 3 years | 36.19 | 27.36 | 132% |
Returns for 5 years | 35.51 | 41.47 | 86% |
Returns for 10 years | 81.79 | 158.92 | 51% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
TTEQ | 30.58 | 0.01 | +0.04% |
T. Rowe Price Technology ETF | |||
IWR | 95.49 | -0.63 | -0.66% |
iShares Russell Mid-Cap ETF | |||
TOUS | 33.31 | -0.40 | -1.19% |
T. Rowe Price International Equity ETF | |||
AVSD | 69.99 | -0.87 | -1.23% |
Avantis Responsible International Eq ETF | |||
GNOM | 9.17 | -0.18 | -1.88% |
Global X Genomics & Biotechnology ETF |